MAIA Biotechnology, Inc.
MAIA
$1.26
-$0.10-7.35%
AMEX
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -18.91% | 46.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -53.88% | 81.20% | |||
| Operating Income | 53.88% | -81.20% | |||
| Income Before Tax | 59.24% | -66.51% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 59.24% | -66.51% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 59.24% | -66.51% | |||
| EBIT | 53.88% | -81.20% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 63.61% | -51.95% | |||
| Normalized Basic EPS | 63.60% | -51.95% | |||
| EPS Diluted | 63.61% | -51.95% | |||
| Normalized Diluted EPS | 63.60% | -51.95% | |||
| Average Basic Shares Outstanding | 12.02% | 9.58% | |||
| Average Diluted Shares Outstanding | 12.02% | 9.58% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||